Tyrone Collins
Overview
Explore the profile of Tyrone Collins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdul Jabbar A, Jaradat M, Hasan M, Yoo J, Jenkins J, Crittendon I, et al.
Cardiovasc Revasc Med
. 2023 Aug;
58:90-97.
PMID: 37596193
Introduction: Multiple device closure (MDC) strategy has been used in treating of complex Atrial septal defects (ASDs) in adults. The safety profile of MDC compared to conventional single device closure...
2.
Abdul Jabbar A, Hasan M, Jenkins J, Collins T, Ramee S
Cardiovasc Revasc Med
. 2020 Nov;
21(10):1291-1298.
PMID: 33246555
Background: Paravalvular leaks (PVLs) are a well-recognized complication of prosthetic valves that are detected up to 18% of all implanted surgical valves. Perioperative morbidity is thought to be lower in...
3.
Krishnan P, Collins T
Interv Cardiol Clin
. 2017 Jun;
3(4):ix-x.
PMID: 28582086
No abstract available.
4.
Bansal A, Bhama J, Patel R, Desai S, Mandras S, Patel H, et al.
Ochsner J
. 2016 Sep;
16(3):210-6.
PMID: 27660567
Background: Outcomes of traditional mechanical support paradigms (extracorporeal membrane oxygenation, intraaortic balloon pump [IABP], and permanent left ventricular assist device [LVAD]) in acute decompensated heart failure have generally been suboptimal....
5.
Benjo A, Cardoso R, Collins T, Garcia D, Macedo F, El-Hayek G, et al.
Catheter Cardiovasc Interv
. 2015 May;
87(2):200-8.
PMID: 25963829
Introduction: Clinical trials have shown a short-term benefit of drug-eluting stents (DES) compared to vascular brachytherapy (VBT) for treatment of in-stent restenosis (ISR). The long-term benefits of DES vs. VBT...
6.
Benjo A, Garcia D, Jenkins J, Cardoso R, Molina T, El-Hayek G, et al.
Open Heart
. 2014 Nov;
1(1):e000154.
PMID: 25392738
Background: Cilostazol is an oral antiplatelet agent currently indicated for treatment of intermittent claudication. There is evidence that cilostazol may reduce femoropopliteal restenosis after percutaneous endovascular intervention. Methods: We searched...
7.
Kilgore A, Lucas V, Collins T, Snyder C
Catheter Cardiovasc Interv
. 2006 Sep;
68(4):629-31.
PMID: 16969875
A 6-week-old male presented in-extremis with obstructed supra-cardiac total anomalous pulmonary venous connection. Balloon dilation and stent implantation in the stenotic segment of the vertical vein relieved the obstruction until...
8.
Chan A, Ramee S, Collins T, Quintana H, White C
Catheter Cardiovasc Interv
. 2003 Aug;
59(4):477-81.
PMID: 12891612
Percutaneous coronary interventions are performed with a high success rate, though failures still occur. Inability to deliver stents to the target lesion is the most common cause for failures. We...
9.
Radike M, Warshawsky D, Caruso J, Goth-Goldstein R, Reilman R, Collins T, et al.
J Toxicol Environ Health A
. 2002 Dec;
65(23):2029-52.
PMID: 12490046
Manufactured gas plant (MGP) sites are contaminated with coal tar and may contain metals such as arsenic (As), cadmium (Cd), chromium (Cr), nickel (Ni), and vanadium (V). These metals are...